Counterfeit Ozempic sold to American distributors at deeply discounted prices is at the center of a federal indictment against two Indian nationals, the US Department of Justice announced on Tuesday. A federal grand jury in the Middle District of Florida charged Swapnadip Roy, 33, and Vicky Ramancha, 37, with conspiracy and smuggling. The case adds to growing scrutiny of illicit markets that have emerged around popular weight-loss drugs. justice
How the Alleged Counterfeit Ozempic Reached US Distributors
According to court documents, the alleged Ozempic smuggling scheme ran from at least July 2023 to April 2024. Prosecutors say Roy and Ramancha obtained the counterfeit Ozempic from China and sold it to US distributors at discounted prices. The Justice Department said the sources in China were unauthorized. 1027wbow
The products were allegedly disguised with care. The counterfeit Ozempic included false packaging, package inserts, pen labels and needles, all intended to convince downstream customers that they were buying genuine medication authorized by the manufacturer. The deception carried obvious commercial appeal, since the drug can cost patients hundreds of dollars per month. 1027wbow
The Justice Department also stated that the operation did not stop when regulators intervened. The scheme allegedly continued after the Food and Drug Administration seized some of the counterfeit Ozempic in December 2023 and issued a public warning about the products. The FDA warning had cautioned consumers against using counterfeit semaglutide found in the US drug supply chain. inkl
Charges and Potential Penalties
The indictment contains six counts against each defendant: one count of conspiracy to commit smuggling and to defraud the United States, three counts of smuggling, and two counts of selling counterfeit drugs and holding counterfeit drugs for sale. If convicted, each man faces a maximum penalty of 71 years in prison.
The Justice Department emphasized that an indictment is merely an allegation and that both defendants are presumed innocent until proven guilty beyond a reasonable doubt in a court of law.
Extradition and Current Status
Roy was arrested in Italy pursuant to an INTERPOL Red Notice. The Justice Department’s Office of International Affairs secured his continued detention and then filed a timely extradition request. He was extradited to the United States and made his initial appearance in Tampa, Florida, where, according to Reuters, he pleaded not guilty. Ramancha remains at large, the department said, according to press reports. 1027wbowinkl
The FDA’s Office of Criminal Investigations is investigating the case. It is being prosecuted by an Assistant US Attorney from the Middle District of Florida and a trial attorney from the Criminal Division’s Health and Safety Unit.
Why Counterfeit Ozempic Matters for the Pharmaceutical Supply Chain
Officials framed the indictment as a defense of the pharmaceutical supply chain. Assistant US Attorney Christopher Murray said his office would not tolerate bad actors “corrupting our pharmaceutical supply chain.” Assistant Attorney General A. Tysen Duva of the Criminal Division warned that counterfeit drugs, especially common ones, threaten the health and safety of Americans who depend on that supply.
An FDA official added that although the US wholesale distribution market is highly regulated, those who subvert its safeguards place consumers at significant risk. He noted that drug safety and quality do not begin or end at the US border, a reminder that enforcement increasingly depends on cooperation with foreign counterparts.
The case arises as GLP-1 medications such as Ozempic have become increasingly popular in the United States for weight loss. Rising demand and high prices create incentives for counterfeiters, which is why regulators continue to urge patients to obtain such medications only through licensed channels. CNBC
Follow SouthAsianDesk on X, Instagram and Facebook for insights on business and current affairs from across South Asia.
